Thrombolysis 3 to 4.5 hours after acute ischemic stroke

New England Journal of Medicine

Volumn 359, Issue 26, 2008, Pages 2839-2841

  Torbey, Michel T ^a   Jauch, Edward ^b   Liebeskind, David S ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; LETTER; PATIENT CARE; PRIORITY JOURNAL; PUBLICATION;

EID: 58149092240     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc082179     Document Type: Letter

References (3)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
3. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study: a randomized controlled trial. JAMA 1999;282:2019-26.